[Association between meningeal Burkitt lymphoma and Epstein-Barr virus in an HIV-infected patient].
Germán
G
López
Francisco
F
Marcilla
Carlos
C
Ramos
Piedad
P
Arazo
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D002051:Burkitt Lymphoma / Q000150:complications / Q000188:drug therapy / Q000821:virology*; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D017809:Fatal Outcome; D005260:Female; D015658:HIV Infections / Q000188:drug therapy / Q000821:virology; D004854:Herpesvirus 4, Human / Q000302:isolation & purification*; D006801:Humans; D008161:Lumbosacral Region; D016483:Lymphoma, AIDS-Related / Q000150:complications / Q000188:drug therapy / Q000821:virology*; D008577:Meningeal Neoplasms / Q000150:complications / Q000821:virology*; D008875:Middle Aged; D020335:Paraparesis / Q000209:etiology; D011239:Prednisolone / Q000008:administration & dosage; D013117:Spinal Cord Compression / Q000209:etiology*; D013125:Spinal Neoplasms / Q000150:complications / Q000821:virology*; D014750:Vincristine / Q000008:administration & dosage
D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone